As a unit that has accompanied rare diseases in Vietnam for nearly three decades, Sanofi has been sponsoring many activities to update diagnostic knowledge, treat rare diseases for healthcare experts, support high-risk screening to help diagnose some congenital metabolic disorders early, ...
Sanofi also supports the community of rare diseases patients, supporting free enzyme replacement therapy that many patients are unable to access drugs for, through the International Humanitarian Drug Access Program implemented since 1997. As of 2025, the program has accompanied hundreds of patients with a total budget of hundreds of billions of VND/year.
Mr. Didier Martin - Director of Pharmaceutical Industry, Sanofi Vietnam expressed: Sanofi has, is and will continue to accompany the community of rare diseases to bring better health care conditions, more effective diagnosis and treatment opportunities. The disease is rare, although rare and drug- scarce, but it is not uncommon to have help and support from society. Sanofi believes that the strength of cooperation will help rare diseases become more widely known, thereby opening up a brighter future for patients.
